Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis

Epidemiology and Infection

Volumn 135, Issue 5, 2007, Pages 868-876

  Mulla, Zuber D ^a,c   Gibbs, S G ^a   Aronoff, D M ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c Paul L Foster School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BINOMIAL DISTRIBUTION; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DEBRIDEMENT; DIABETES MELLITUS; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; HYPERBARIC OXYGEN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NECROTIZING FASCIITIS; PREDICTION; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS; UNITED STATES;

ADULT; AGED; FASCIITIS, NECROTIZING; FEMALE; HEALTH CARE COSTS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 34547431706     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806007448     Document Type: Article

References (25)

1. Young MH, et al. Therapies for necrotising fasciitis. Expert Opinion on Biological Therapy 2006; 6: 155-165.
2. Widjaja AB, et al. The hospital costs of treating necrotizing fasciitis. Australian & New Zealand Journal of Surgery 2005; 75: 1059-1064.
3. Faucher LD, et al. Burn center management of necrotizing soft-tissue surgical infections in unburned patients. American Journal of Surgery 2001; 182: 563-569.
4. Sudarsky LA , et al. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Annals of Surgery 1987; 206: 661-665.
5. Kaul R, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. American Journal of Medicine 1997; 103: 18-24.
6. Tiu A, et al. Necrotizing fasciitis: Analysis of 48 cases in South Auckland, New Zealand. Australian & New Zealand Journal of Surgery 2005; 75: 32-34.
7. Wong CH, et al. Necrotizing fasciitis: Clinical presentation, microbiology, and determinants of mortality. Journal of Bone and Joint Surgery - American Volume 2003; 85A: 1454-1460.
8. Tillou A, et al. Necrotizing soft tissue infections : improved outcome with modern care. American Surgeon 2004; 70 841-844.
9. Jallali N, Withey S, Butler PE. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. American Journal of Surgery 2005; 189: 462-466.
10. Lee AH, et al. A robustified modeling approach to analyze pediatric length of stay. Annals of Epidemiology 2005; 15: 673-677.
11. Szklo M, Nieto FJ. Epidemiology: Beyond the basics. Gaithersburg, MD: Aspen Publishers, 2000, pp. 180.
12. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia, Pennsylvania : Lippincott Williams & Wilkins, 1998, pp. 125.
13. Robbins AS, Chao SY, Fonseca VP. What's the relative risk ? A method to directly estimate risk ratios in cohort studies of common outcomes. Annals of Epidemiology 2002; 12 452-454.
14. Allison PD. Logistic Regression using the SAS System: Theory and application. Cary, NC: SAS Institute, Inc., 1991, pp. 48-51.
15. Cole SR. Analysis of complex survey data using SAS. Computer Methods & Programs in Biomedicine 2001; 64: 65-69.
16. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd edn. New York: John Wiley and Sons, 2000, pp. 313.
17. Florida Vital Statistics Annual Report, Population. 2001. (http://www.flpublichealth.com/VSBOOK/pdf/2001/Population.pdf). Accessed 8 March 2006.
18. Childers BJ, et al. Necrotizing fasciitis: A fourteen-year retrospective study of 163 consecutive patients. American Surgeon 2002; 68: 109-116.
19. Schnall SB. Necrotizing fasciitis: Clinical presentation, microbiology, and determinants of mortality [Letter]. Journal of Bone and Joint Surgery - American Volume 2004; 86A: 869.
20. Kao LS, et al. The impact of diabetes in patients with necrotizing soft tissue infections. Surgical Infections 2005; 6 427-438.
21. Iezzoni LI, et al. Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality ? Journal of the American Medical Association 1992; 267: 2197-2203.
22. Mulla ZD, Leaverton PE, Wiersma ST. Invasive group A streptococcal infections in Florida. Southern Medical Journal 2003; 96: 968-973.
23. Endorf FW, Supple KG, Gamelli RL. The evolving characteristics and care of necrotizing soft-tissue infections. Burns 2005; 31 269-273.
24. Stevens DL, et al. The Eagle effect revisited : Efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. Journal of Infectious Diseases 1988; 158: 23-28.
25. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatric Infectious Disease Journal 1999; 18: 1096-1100.